<code id='C25F3A34E4'></code><style id='C25F3A34E4'></style>
    • <acronym id='C25F3A34E4'></acronym>
      <center id='C25F3A34E4'><center id='C25F3A34E4'><tfoot id='C25F3A34E4'></tfoot></center><abbr id='C25F3A34E4'><dir id='C25F3A34E4'><tfoot id='C25F3A34E4'></tfoot><noframes id='C25F3A34E4'>

    • <optgroup id='C25F3A34E4'><strike id='C25F3A34E4'><sup id='C25F3A34E4'></sup></strike><code id='C25F3A34E4'></code></optgroup>
        1. <b id='C25F3A34E4'><label id='C25F3A34E4'><select id='C25F3A34E4'><dt id='C25F3A34E4'><span id='C25F3A34E4'></span></dt></select></label></b><u id='C25F3A34E4'></u>
          <i id='C25F3A34E4'><strike id='C25F3A34E4'><tt id='C25F3A34E4'><pre id='C25F3A34E4'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:71
          Jennifer Doudna Feng Zhang CRISPR
          CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

          The revolution started in silence.

          Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

          advertisement

          No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness
          Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

          17:55UkrainianPresidentVolodymyrZelenskyyspeakswithABCNews'MarthaRaddatz.YuriyBoyko/ABCNewsKYIV,Ukra

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          The U.S. needs a new definition of substance use “recovery”

          Adobe“WhenIuseaword,”oneof19thcenturyBritishauthorandmathematicianLewisCarroll’scharactersoncesaid,“